Figure_1.tif (790.25 kB)
Key milestones in the co-development of vemurafenib and the cobas® 4800 BRAF V600 Mutation Test.
figure
posted on 2013-02-19, 17:16 authored by Fernando Lopez-Rios, Barbara Angulo, Belen Gomez, Debbie Mair, Rebeca Martinez, Esther Conde, Felice Shieh, Jeffrey Vaks, Rachel Langland, H. Jeffrey Lawrence, David Gonzalez de CastroPhases of companion diagnostic (CoDx) development in green, drug (Rx) development in blue. IDE = Investigational Device Exemption; IND = Investigational New Drug Application; MAA = Marketing Authorisation Application; NDA = New Drug Application; PMA = Premarket Approval Application; RMS = Roche Molecular Systems, Inc.
